XAGE LONGEVITY HEALTH HLDGS INC revenue, earnings and financials
For the quarter ended June 30, 2026, LONGEVITY HEALTH HLDGS INC reported revenue of $396K (down 21.4% from a year earlier), net income of −$1.88M and diluted EPS of n/a; over the last four quarters revenue was $1.69M and net income −$6.83M; for the fiscal year ended December 2025 revenue was $1.91M, up 3701.4% on the year before.
XAGE annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $1.91M, gross profit $1.09M, operating income −$7.11M, net income −$6.91M (margin -361.0%), EPS −$4.83
- Fiscal year ended Dec 2024: revenue $50.3K, gross profit $44.0K, operating income −$5.00M, net income −$10.4M (margin -20605.5%), EPS −$14.56
- Fiscal year ended Dec 2023: revenue $0, gross profit $0, operating income −$5.94M, net income −$15.4M (margin n/a), EPS −$1.46
- Fiscal year ended Dec 2022: revenue n/a, gross profit n/a, operating income −$5.51M, net income −$9.05M (margin n/a), EPS −$5.47
- Fiscal year ended Dec 2021: revenue n/a, gross profit n/a, operating income −$467K, net income −$329K (margin n/a), EPS n/a
XAGE quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $396K (down 21.4% year over year), net income −$1.88M, EPS n/a
- Quarter ended Mar 31, 2026: revenue $392K (down 23.2% year over year), net income −$1.43M, EPS −$0.75
- Quarter ended Dec 31, 2025 (from the annual report): revenue $473K (up 2606.0% year over year), net income −$2.08M, EPS −$0.92
- Quarter ended Sep 30, 2025: revenue $426K (up 1975.5% year over year), net income −$1.43M, EPS −$0.83
- Quarter ended Jun 30, 2025: revenue $504K (up 3987.8% year over year), net income −$1.89M, EPS −$1.56
- Quarter ended Mar 31, 2025: revenue $510K, net income −$1.51M, EPS −$1.52
- Quarter ended Dec 31, 2024 (from the annual report): revenue $17.5K, net income −$914K, EPS −$1.37
- Quarter ended Sep 30, 2024: revenue $20.5K, net income −$2.88M, EPS −$4.13
- Quarter ended Jun 30, 2024: revenue $12.3K, net income −$3.30M, EPS −$4.78
- Quarter ended Mar 31, 2024: revenue $0, net income −$3.27M, EPS −$4.28
- Quarter ended Dec 31, 2023 (from the annual report): revenue n/a, net income $3.16M, EPS $6.07
- Quarter ended Sep 30, 2023: revenue $0, net income −$11.5M, EPS −$0.62
- Quarter ended Jun 30, 2023: revenue $0, net income −$5.31M, EPS −$5.00
- Quarter ended Mar 31, 2023: revenue n/a, net income −$1.83M, EPS −$1.91
- Quarter ended Dec 31, 2022 (from the annual report): revenue n/a, net income −$2.11M, EPS n/a
- Quarter ended Sep 30, 2022: revenue $0, net income −$6.07M, EPS −$6.74
- Quarter ended Jun 30, 2022: revenue n/a, net income −$347K, EPS n/a
- Quarter ended Mar 31, 2022: revenue n/a, net income −$528K, EPS n/a
- Quarter ended Dec 31, 2021 (from the annual report): revenue n/a, net income −$364K, EPS n/a
- Quarter ended Sep 30, 2021: revenue n/a, net income $42.7K, EPS n/a
XAGE cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$3.33M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$3.89M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$8.35M, share buybacks $0
- Fiscal year ended Dec 2022: operating cash flow −$3.43M, share buybacks $2.29K
- Fiscal year ended Dec 2021: operating cash flow −$451K, share buybacks n/a
XAGE balance sheet
- Jun 30, 2026: cash $35.5K, total assets $1.06M, total liabilities $9.75M, shareholders' equity −$8.70M
- Mar 31, 2026: cash $313K, total assets $1.64M, total liabilities $8.54M, shareholders' equity −$6.89M
- Dec 31, 2025: cash $707K, total assets $2.37M, total liabilities $8.23M, shareholders' equity −$5.87M
- Sep 30, 2025: cash n/a, total assets $3.30M, total liabilities $7.28M, shareholders' equity −$3.98M
- Jun 30, 2025: cash n/a, total assets $3.72M, total liabilities $7.46M, shareholders' equity −$3.74M
- Mar 31, 2025: cash n/a, total assets $3.34M, total liabilities $7.14M, shareholders' equity −$3.81M
- Dec 31, 2024: cash $157K, total assets $1.47M, total liabilities $6.19M, shareholders' equity −$4.71M
- Sep 30, 2024: cash $1.14M, total assets $2.44M, total liabilities $6.51M, shareholders' equity −$4.06M
What is XAGE's revenue?
LONGEVITY HEALTH HLDGS INC reported $1.69M of revenue over its last four quarters, through June 30, 2026.
Is XAGE profitable?
No. LONGEVITY HEALTH HLDGS INC lost $6.83M over the last four quarters.